Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

8 results
  1. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    ... taxane agent (e.g., paclitaxel, docetaxel) or liposomal doxorubicin.7-9 For recurrence, several chemotherapy regimens (e.g., docetaxel, paclitaxel, gemcitabine, liposomal doxorubicin, topotecan and etoposide) may be ...
  2. NLM Digital Collections - Management of epithelial ovarian cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), 2013
    ... cancer what is the optimal chemotherapy 6.3 regimen? Consider: platinum (carboplatin), taxanes (paclitaxel), topotecan, bevacizumab, gemcitabine, trabectedin, pegylated liposomal doxorubicin; consider mono and combination therapies (eg single agent ...
  3. NLM Digital Collections - Indication-specific pricing of pharmaceuticals in the United States health care system : a ... 
    Publication: Boston, MA : Institute for Clinical and Economic Review, March 2016
    ... EC in July 2014, was: in combination with paclitaxel, topotecan, or ... prior chemotherapy regimens and who have not received prior therapy with ...
  4. NLM Digital Collections - Treatment of primary breast cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), September 2013
    ... A, et al. Feasibility and tolerability of sequential doxorubicin/ paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its ...
  5. NLM Digital Collections - Management of lung cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), February 2014
    ... with advanced non-small cell lung cancer comparing paclitaxel-cisplatin- etoposide versus cisplatin- previously treated with platinum-containing chemotherapy etoposide as first-line treatment in patients with small-cell lung regimens. The TAX 320 Non-Small Cell Lung Cancer ...
  6. NLM Digital Collections - Pathological complete response in neoadjuvant treatment of high-risk early-stage breast ... 
    Publication: [Silver Spring, MD] : United States Food and Drug Administration, Oncology Center of Excellence, July 2020
    ... Buzdar A et al., 2007, Neoadjuvant Therapy With Paclitaxel Followed By ... Treated With the Same Regimen, Clin Cancer Res, 13:228-233. Cortazar P ...
  7. NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ... 
    Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, DC : For sale by the Supt. of Docs., U.S. G.P.O., 1999
    ... Agents Adrenomimetics see Adrenergic Agents Adrenomyeloneuropathy see Adrenoleukodystrophy Adriamycin see Doxorubicin Adsorbents see Dermatologic Agents; Gastrointestinal Agents; ...
  8. NLM Digital Collections - An analysis of reported adverse drug reactions 
    Publication: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, [2014]
    ... matologic in nature (e.g., rash, red skin, DOXOrubicin, vinCRIStine, predni- began feeling flush. Infusion was itching) ... hospitals and health systems. events. The ADRs for PACLitaxel and (CARBOplatin, CISplatin, oxaliplatin) All of the reports ( ...